Home > Balance Sheet > BIOCON

BIOCON
Contingent Liabilities

    Back to Balance Sheet
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Contingent Liabilities ₹1,136 Cr₹948 Cr₹844 Cr₹700 Cr₹717 Cr

What is the latest Contingent Liabilities ratio of BIOCON ?

The latest Contingent Liabilities ratio of BIOCON is ₹1,136 Cr based on Mar2024 Consolidated results.
Year Contingent Liabilities
Mar2024₹1,136 Cr
Mar2023₹948 Cr
Mar2022₹844 Cr
Mar2021₹700 Cr
Mar2020₹717 Cr

How is Contingent Liabilities of BIOCON Trending?

Years Contingent Liabilities % Change
Mar2024 ₹1,136 Cr
19.81
Mar2023 ₹948 Cr
12.25
Mar2022 ₹844 Cr
20.63
Mar2021 ₹700 Cr
-2.37
Mar2020 ₹717 Cr -

Compare Contingent Liabilities of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹41,594.8 Cr -1.1% -1.8% 40.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,838.0 Cr 1% 4.6% 47.5% Stock Analytics
DIVIS LABORATORIES ₹156,107.0 Cr 1% -3.2% 59.3% Stock Analytics
CIPLA ₹120,270.0 Cr -1.1% -0.3% 20.7% Stock Analytics
DR REDDYS LABORATORIES ₹113,077.0 Cr 2.2% 12.1% 21.6% Stock Analytics
ZYDUS LIFESCIENCES ₹96,553.2 Cr -2.7% 0.8% 43.8% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-1.1%

-1.8%

40.4%

SENSEX

-2.1%

-2%

11.3%


You may also like the below Video Courses